• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 101967-950
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Implant Pain (4561)
Event Date 05/08/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.In addition, the user guide mentions that the adhesive patches may cause reaction or skin irritation and any medical issues or symptoms caused should be reported to the health care provider.In this case, the er physician who treated the patient for intense pain suggested sensor removal because they thought the issue might be due to sensor.However, the patient's hcp did an ultrasound and found tendon inflammation and bursitis.The patient's hcp said the issue was not due to sensor and a removal is not needed.The patient is currently doing fine after taking paracetamol treatment.The er physician also suggested patient to take painkillers or inflammatory meds in required.This incident does not require any further investigation and the patient should see doctor in case of any medical guidance.
 
Event Description
Senseonics was made aware of an incident where patient was admitted to hospital due to intense pain at the insertion site on (b)(6) 2023.The pain began one month after the sensor insertion on (b)(6) 2023.Patient also had symptoms such as muscle stiffness and burning sensation.The emergency room (er) physician suggested patient to urgently remove sensor and was treated with paracetamol via iv.The patient consulted physician who did ultrasound and found tendon inflammation and bursitis.The physician said the event was not related to sensor and it does not have to be removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18117089
MDR Text Key327882476
Report Number3009862700-2023-00228
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number101967-950
Device Catalogue NumberFG-4500-50-302
Device Lot NumberWP09010
Was Device Available for Evaluation? No
Date Manufacturer Received06/22/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-